Palvella Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Palvella Therapeutics, Inc. (PVLA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents83.607.3516.05117.7670.44104.15128.11
Cash & Short-Term Investments83.607.3516.05117.7670.44104.15128.11
Accounts Receivable0.366.0411.043.311.716.792.70
Inventory0.000.000.000.000.000.000.00
Other Current Assets2.300.200.475.676.140.000.00
Total Current Assets88.237.5516.52127.6375.72115.01135.38
Non-Current Assets
Property, Plant & Equipment (Net)0.000.0016.9923.0325.9822.945.05
Other Non-Current Assets0.000.001.372.903.313.150.91
Total Non-Current Assets0.000.0022.0725.9429.2926.085.96
Total Assets88.237.5516.52153.56105.01141.10141.34
Current Liabilities
Accounts Payable4.590.943.188.619.5211.699.14
Accrued Liabilities1.211.081.680.000.000.000.00
Other Current Liabilities3.170.170.1616.842.760.460.95
Total Current Liabilities12.042.365.7850.5622.1527.0048.08
Non-Current Liabilities
Long-Term Debt0.008.0512.2413.8415.9315.480.00
Other Non-Current Liabilities11.948.0532.420.000.010.000.03
Total Non-Current Liabilities13.599.0733.9252.2451.8462.7453.33
Total Liabilities25.6311.4339.70102.8173.9889.75101.41
Stockholders' Equity
Common Stock0.010.000.000.000.000.000.00
Retained Earnings-93.74-76.30-94.99-256.32-211.70-174.18-147.07
Accumulated Other Comprehensive Income0.000.000.000.000.00-2.00-2.98
Additional Paid-in Capital156.331.821.22307.00242.67227.47189.93
Shares Outstanding11.0111.0111.220.000.000.000.00
Total Stockholders' Equity62.61-3.88-23.1750.7631.0351.3539.94
Total Liabilities & Equity88.237.5516.52153.56105.01141.10141.34